Randomized Controlled Trial of Fixed Rate Versus Rate Responsive Pacing after Radiofrequency Atrioventricular Junction Ablation: Quality of Life, Ventricular Refractoriness, and Paced QT Dispersion

Journal of Cardiovascular Electrophysiology

Volumn 14, Issue 11, 2003, Pages 1163-1170

  Duff, Henry J ^a   Raj, Satish R ^a   Exner, Derek V ^a   Sheldon, Robert S ^a   Roach, Dan ^a   Mitchell, L Brent ^a   Wyse, D George ^a   Morck, Margaret ^a   Gillis, Anne M ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Atrioventricular junction ablation; Electrical remodeling; Quality of life

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; EXERCISE; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART BEAT; HEART MUSCLE REFRACTORY PERIOD; HEART PACING; HEART RIGHT VENTRICLE; HEART VENTRICLE TACHYCARDIA; HOSPITAL DISCHARGE; HUMAN; INCIDENCE; MALE; MORBIDITY; PRIORITY JOURNAL; QT INTERVAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL;

AGED; ATRIAL FIBRILLATION; ATRIOVENTRICULAR NODE; CARDIAC PACING, ARTIFICIAL; CATHETER ABLATION; COMBINED MODALITY THERAPY; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; POSTOPERATIVE CARE; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 0344633604     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1540-8167.2003.03168.x     Document Type: Article

References (32)

1. Brignole M, Gianfranchi L, Menozzi C, Alboni P, Musso G, Bongiorni MG, Gasparini M, Raviele A, Lolli G, Paparella N, Acquarone S: Assessment of atrioventricular junction ablation and DDDR mode-switching pacemaker versus pharmacological treatment in patients with severely symptomatic paroxysmal atrial fibrillation: A randomized controlled study. Circulation 1997;96:2617-2624.
2. Brignole M, Menozzi C, Gianfranchi L, Musso G, Mureddu R, Bottoni N, Lolli G: Assessment of atrioventricular junction ablation and VVIR pacemaker versus pharmacological treatment in patients with heart failure and chronic atrial fibrillation. Circulation 1998;98:953-960.
3. Gillis AM, Wyse DG, Connolly SJ, Dubuc M, Philippon F, Yee R, Lacombe P, Rose MS, Kerr CD: Atrial pacing peri-ablation for prevention of paroxysmal atrial fibrillation. Circulation 1999;99:2553-2558.
4. Brignole M, Gianfranchi L, Menozzi C, Bottoni N, Bollini R, Lolli G, Oddone D, Gaggioli G: Influence of atrioventricular junction radiofrequency ablation in patients with chronic AF and flutter on quality of life and cardiac performance. Am J Cardiol 1994;74:242-246.
5. Heinz G, Siostrzonek P, Kreiner G, Gossinger H: Improvement in left ventricular systolic function after successful radiofrequency His bundle ablation for drug refractory, chronic AF and recurrent atrial flutter. Am J Cardiol 1992;69:489-492.
6. Jensen SM, Bergfeldt L, Rosenqvist M: Long-term follow-up of patients treated by radiofrequency ablation of the atrioventricular junction. Pacing Clin Electrophysiol 1995;18:1609-1614.
7. Olgin JE, Scheinman MM: Comparison of high energy direct current and radiofrequency catheter ablation of the atrioventricular junction. J Am Coll Cardiol 1993;21:557-564.
8. Lee SH, Chen SA, Tai CT, Chiang CE, Wen ZC, Cheng JJ, Ding YA, Chang MS: Comparisons of the quality of life and cardiac performance after complete atrioventricular junction ablation and atrioventricular junction modification in patients with medically refractory atrial fibrillation. J Am Coll Cardiol 1998;31:637-644.
9. Rosenquvist M, Lee MA, Moulinier L, Springer MJ, Abbott JA, Wu J, Langberg JJ, Griffin JC, Scheinman MM: Long-term follow-up of patients after transcatheter direct current ablation of the atrioventricular junction. J Am Coll Cardiol 1990;16:1467-1474.
10. Lemery R, Brugada P, Cheriex E, Wellens HJ: Reversibility of tachycardia-induced left ventricular dysfunction after closed-chest catheter ablation of the atrioventricular junction for intractable atrial fibrillation. Am J Cardiol 1987;60:1406-1408.
11. Lee MA, Dae MW, Langberg JJ, Griffin JC, Chin MC, Finkbeiner WE, O'Connell JW, Botvinick E, Scheinman MM, Rosenqvist M: Effects of long-term right ventricular apical pacing on left ventricular perfusion, innervation, function and histology. J Am Coll Cardiol 1994;24:225-232.
12. Krebs ME, Szwed JM, Shinn T, Miles WM, Zipes DP: Short-term rapid ventricular pacing prolongs ventricular refractoriness in patients. J Cardiovasc Electrophysiol 1998;9:1036-1042.
13. Hamdan MH, Page RL, Sheehan CJ, Zagrodzky JD, Wasmund SL, Ramaswamy K, Joglar JA, Smith ML: Increased sympathetic activity after atrioventricular junction ablation in patients with chronic atrial fibrillation. J Am Coll Cardiol 2000;36:151-158.
14. Azar KR, Lippman N, Kluger J: Recurrent polymorphic ventricular tachycardia complicating radiofrequency catheter ablation of the atrioventricular junction. Pacing Clin Electrophysiol 1998;21:1837-1840.
15. Geelen P, Brugada J, Andries E, Brugada P: Ventricular fibrillation and sudden death after radiofrequency catheter ablation of the atrioventricular junction. Pacing Clin Electrophysiol 1997;20:343-348.
16. Darpo B, Walfridsson H, Aunes M, Bergfeldt L, Edvardsson N, Linde C, Lurje L, van der Linden M, Rosenqvist M: Incidence of sudden death after radiofrequency ablation of the atrioventricular junction for atrial fibrillation. Am J Cardiol 1997;80:1174-1177.
17. Peters RH, Wever EF, Hauer RN, Wittkampf FH, Robles de Medina EO: Bradycardia dependent QT prolongation and ventricular fibrillation following catheter ablation of the atrioventricular junction with radiofrequency energy. Pacing Clin Electrophysiol 1994;17:108-112.
18. Conti JB, Mills RM Jr, Woodard DA, Curtis AB: QT dispersion is a marker for life-threatening ventricular arrhythmias after atrioventricular nodal ablation using radiofrequency energy. Am J Cardiol 1997;79:1412-1414.
19. Raj SR, Gillis AM, Mitchell LB, Wyse DG, Sheldon RS, Exner DV, Morck M, Duff HJ: Paced QT dispersion and QT morphology after radiofrequency AV Junction ablation: Impact of left ventricular function. Pacing Clin Electrophysiol (In press).
20. Ware JE Jr, Nelson EC, Sherbourne CD, Stewart AL: Preliminary tests on a 6-item general health survey: A patient application. In Stewart AL, Ware JE Jr, eds: Measuring Functioning and Well-Being. The Medical Outcomes Study Approach. Durham and London: Duke University, 1992:291-303.
21. Irvine J, Dorian P, Baker B, O'Brien BJ, Roberts R, Gent M, Newman D, Connolly SJ: Quality of life in the Canadian Implantable Defibrillator Study (CIDS). Am Heart J 2002;144:282-289.
22. Sulke N, Dritsas A, Bostock J, Wells A, Morris R, Sowton E: "Subclinical" pacemaker syndrome: A randomised study of symptom free patients with ventricular demand (VVI) pacemakers upgraded to dual chamber devices. Br Heart J 1992;67:57-64.
23. Kay GN, Ellenbogen KA, Giudici M, Redfield MM, Jenkins LS, Mianulli M, Wilkoff B: The Ablate and Pace Trial: A prospective study of catheter ablation of the AV conduction system and permanent pacemaker implantation for treatment of atrial fibrillation. APT Investigators. J Interv Card Electrophysiol 1998;2:121-135.
24. Maison-Blanche P, Coumel P: Changes in repolarization dynamicity and the assessment of the arrhythmic risk. Pacing Clin Electrophysiol 1997;20:2614-2624.
25. Dawodu AA, Monti F, Iwashiro K, Schiariti M, Chiavarelli R, Puddu PE: The shape of human atrial action potential accounts for different frequency-related changes in vitro. Int J Cardiol 1996;54:237-249.
26. Ozcan C, Jahangir A, Friedman PA, Patel PJ, Munger TM, Rea RF, Lloyd MA, Packer DL, Hodge DO, Gersh BJ, Hammill SC, Shen WK: Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation. N Engl J Med 2001;344:1043-1051.
27. Gillis AM, Geonzon RA, Mathison HJ, Kulisz E, Lester WM, Duff HJ: The effects of barium, dofetilide and 4-aminopyridine (4-AP) on ventricular repolarization in normal and hypertrophied rabbit heart. J Pharmacol Exp Ther 1998;285:262-270.
28. Priori SG, Napolitano C, Diehl L, Schwartz PJ: Dispersion of the QT interval. A marker of therapeutic efficacy in the idiopathic long QT syndrome. Circulation 1994;89:1681-1689.
29. Malik M, Acar B, Gang Y, Yap YG, Hnatkova K, Camm AJ: QT dispersion does not represent electrocardiographic interlead heterogeneity of ventricular repolarization. J Cardiovasc Electrophysiol 2000;11:835-843.
30. The David Investigators: Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator. JAMA 2002;288:3115-3123.
31. Andersen HR, Nielsen JC, Thomsen PE, Thuesen L, Mortensen PT, Vesterlund T, Pedersen AK: Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome. Lancet 1997;350:1210-1216.
32. Ca-L is the major determinant of use-dependent facilitation in rat cardiomyocytes. J Physiol 2003;547 (Pt 3):797-805.